wada aod9604 prohibited list 2025 published World Anti-Doping Agency (WADA) Prohibited

Pyridoxine (B) in high doses is known to interact with certain drugs: it can reduce the therapeutic efficacy of levodopa by increasing peripheral conversion of levodopa to dopamine (vitamin B speeds up decarboxylation)

However, it is recommended to avoid strenuous physical activity or heavy lifting for a short period after the injections to minimize the risk of bruising or swelling at the injection site

While interactions are rare, well ensure everything is aligned for safety and synergy

AOD-9604 Peptide Synthesized and Lyophilized in Canada by Koi Peptides Domestic Synthesis at a Canadian Facility Assembly of the 16-residue chain is carried out by solid-phase peptide synthesis at a Canadian manufacturing partner, with the Cys7-Cys14 disulfide bond formed during the oxidation step before final purification